[Optimal chemotherapy for advanced and recurrent breast cancer patients]

Nihon Rinsho. 2007 Jun 28:65 Suppl 6:523-9.
[Article in Japanese]
No abstract available

Publication types

  • Review

MeSH terms

  • Anthracyclines / administration & dosage
  • Antibodies, Monoclonal / administration & dosage
  • Antibodies, Monoclonal, Humanized
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Biomarkers, Tumor
  • Bone Neoplasms / drug therapy
  • Bone Neoplasms / secondary
  • Breast Neoplasms / drug therapy*
  • Breast Neoplasms / pathology
  • Capecitabine
  • Deoxycytidine / administration & dosage
  • Deoxycytidine / analogs & derivatives
  • Diphosphonates / therapeutic use
  • Docetaxel
  • Female
  • Fluorouracil / administration & dosage
  • Fluorouracil / analogs & derivatives
  • Humans
  • Informed Consent
  • Neoplasm Recurrence, Local / drug therapy*
  • Paclitaxel / administration & dosage
  • Palliative Care
  • Patient Care Team
  • Quality of Life
  • Receptor, ErbB-2
  • Receptors, Estrogen
  • Silicates / administration & dosage
  • Taxoids / administration & dosage
  • Titanium / administration & dosage
  • Trastuzumab

Substances

  • Anthracyclines
  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Biomarkers, Tumor
  • Diphosphonates
  • Receptors, Estrogen
  • Silicates
  • Taxoids
  • Deoxycytidine
  • titanium silicide
  • Docetaxel
  • Capecitabine
  • Titanium
  • Receptor, ErbB-2
  • Trastuzumab
  • Paclitaxel
  • Fluorouracil